| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |